Publish date:

Jim Cramer: I Don't Have a Catalyst for Celgene or Gilead

After analyzing the biotech space, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer doesn't have a catalyst for Celgene or Gilead.
Author:

After analyzing the biotech space, TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer doesn't have a catalyst for Celgene (CELG) - Get Celgene Corporation Report or Gilead (GILD) - Get Gilead Sciences, Inc. (GILD) Report .

Cramer addressed these stocks on Thursday's edition of CNBC's Mad Money.

Meanwhile, President Trump is set to deliver a speech on drug pricing on Friday. 

TheStreet Recommends

For exclusive investing insight from Jim Cramer, get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!